HIV
Pfizer’s Celsentri approved in Europe
September 25, 2007Research and Development, Sales and Marketing HIV
Pfizer's Celsentri has been approved in Europe, making it the first in a new, oral class of HIV drugs in …
FDA approves Pfizer’s first-in-class HIV drug
August 8, 2007Sales and Marketing HIV
Pfizer has won US approval for Selzentry, making it the first new class of oral HIV medicines to reach the …
Gates Foundation could rival pharma, analysts warn
May 15, 2007Sales and Marketing Gates Foundation, HIV, TB, vaccines
The pharmaceutical industry could suffer a blow to its reputation, and could even suffer commercially, if it fails to appreciate …
Abbott lowers prices on HIV drugs
April 12, 2007Sales and Marketing HIV, par
Intervention from the World Health Organisation has spurred Abbott to lower its prices on HIV drugs in developing countries.The company …
HIV market: collaborative combinations
March 26, 2007Research and Development, Sales and Marketing HIV, drug development, marketing
Two new HIV drugs, from Tibotec and Gilead, have been shown to be viable late-stage pipeline candidates. However, both TMC278 …
Abbott withdraws HIV drugs from Thailand after patent row
March 21, 2007Sales and Marketing HIV
Abbott Laboratories' tit-for-tat decision to withold new HIV treatments from Thailand has drawn an angry response from the Aids Healthcare …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
